Leerink Partnrs Analysts Cut Earnings Estimates for Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Investment analysts at Leerink Partnrs lowered their Q2 2024 EPS estimates for Acadia Healthcare in a research note issued on Monday, June 17th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings per share of $0.87 for the quarter, down from their prior forecast of $0.92. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.52 per share. Leerink Partnrs also issued estimates for Acadia Healthcare’s FY2024 earnings at $3.55 EPS.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share for the quarter, topping analysts’ consensus estimates of $0.80 by $0.04. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The business had revenue of $768.10 million during the quarter, compared to the consensus estimate of $779.20 million. During the same quarter last year, the firm earned $0.75 earnings per share. Acadia Healthcare’s quarterly revenue was up 9.1% on a year-over-year basis.

ACHC has been the subject of several other reports. TheStreet raised shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research note on Monday, March 4th. UBS Group lifted their price target on shares of Acadia Healthcare from $88.00 to $102.00 and gave the company a “buy” rating in a research note on Wednesday, February 28th. TD Cowen decreased their price target on shares of Acadia Healthcare from $101.00 to $91.00 and set a “buy” rating for the company in a research note on Friday, May 17th. Barclays decreased their price target on shares of Acadia Healthcare from $91.00 to $89.00 and set an “overweight” rating for the company in a research note on Wednesday, May 15th. Finally, StockNews.com downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Tuesday, May 21st. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $87.56.

Acadia Healthcare Trading Up 3.8 %

ACHC opened at $68.29 on Wednesday. Acadia Healthcare has a 1-year low of $62.04 and a 1-year high of $87.77. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.63. The company has a market cap of $6.34 billion, a P/E ratio of -487.75, a price-to-earnings-growth ratio of 1.97 and a beta of 1.32. The company has a fifty day moving average price of $69.15 and a two-hundred day moving average price of $76.22.

Institutional Trading of Acadia Healthcare

A number of institutional investors have recently modified their holdings of ACHC. Cetera Advisors LLC bought a new position in shares of Acadia Healthcare in the 1st quarter worth $540,000. Iron Triangle Partners LP boosted its stake in shares of Acadia Healthcare by 14.0% in the 1st quarter. Iron Triangle Partners LP now owns 902,813 shares of the company’s stock valued at $71,521,000 after purchasing an additional 110,820 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its stake in shares of Acadia Healthcare by 2.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 133,093 shares of the company’s stock valued at $10,545,000 after purchasing an additional 2,584 shares in the last quarter. MQS Management LLC purchased a new stake in Acadia Healthcare during the 1st quarter valued at $322,000. Finally, CANADA LIFE ASSURANCE Co boosted its position in Acadia Healthcare by 14.7% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 58,505 shares of the company’s stock valued at $4,637,000 after buying an additional 7,491 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.